- Trials with a EudraCT protocol (3)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
3 result(s) found for: Survey methodology.
Displaying page 1 of 1.
EudraCT Number: 2014-003876-22 | Sponsor Protocol Number: CCDZ173X2201 | Start Date*: Information not available in EudraCT |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: An open-label, non-randomized, within-patient dose-finding study followed by a randomized, subject, investigator and sponsor-blinded placebo controlled study to assess the efficacy and safety of CD... | ||
Medical condition: APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/ p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Completed) NL (Completed) IE (Completed) FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005972-41 | Sponsor Protocol Number: A9001464 | Start Date*: 2012-08-22 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 4 MULTICENTER, OPEN-LABEL, PILOT STUDY OF PREGABALIN AND PREDICTION OF TREATMENT RESPONSE IN PATIENTS WITH POSTHERPETIC NEURALGIA. | |||||||||||||
Medical condition: Postherpetic Neuralgia (PHN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001319-36 | Sponsor Protocol Number: FIERCE-21(B-701-U21) | Start Date*: 2017-08-23 | |||||||||||
Sponsor Name:BioClin Therapeutics, Inc. | |||||||||||||
Full Title: A Dose Escalation, Expansion Study of Vofatamab (B 701) Alone, Plus Docetaxel, or Versus Docetaxel in Subjects with Locally Advanced or Metastatic Urothelial Cell Carcinoma who have Relapsed After,... | |||||||||||||
Medical condition: Treatment of progressed or refractory metastatic UCC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
